Effect of pulmonary rehabilitation on dyspnea and exercise tolerance in patients with interstitial lung disease: a systematic review

References

• Hillegass E. Essentials of cardiopulmonary physical therapy. 4th ed. St. Louis, Missouri: Elsevier Mosby; 2017.
   Google Scholar
• Olson AL, Gifford AH, Inase N, et al. The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype. Eur Respir Rev. 2018;27(150):180077.
   PubMed Web of Science ®Google Scholar
• Spruit M, Singh S, Garvey C, et al. An official american thoracic society/european respiratory society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Med. 2013;188(8):13–64.
   PubMed Web of Science ®Google Scholar
• Campbell ML. Dyspnea. Crit Care Nurs Clin North Am. 2017;29(4):461–470.
   PubMed Web of Science ®Google Scholar
• Kasawara K, Castellanos M, Hanada M, et al. Pathophysiology of muscle in pulmonary and cardiovascular conditions. Cardiopulm Phys Ther J. 2019;30(1):5–14.
   Google Scholar
• Mathai SC, Danoff SK. Management of interstitial lung disease associated with connective tissue disease. BMJ. 2016;352:h6819.
   PubMed Web of Science ®Google Scholar
• Nathan SD, Shlobin OA, Weir N, et al. Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. Chest. 2011;140(1):221–229.
   PubMed Web of Science ®Google Scholar
• Lynch DA, Godwin JD, Safrin S, et al. High-resolution computed tomography in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2005;172(4):488–493.
   PubMed Web of Science ®Google Scholar
• Richeldi L, Varone F, Bergna M, et al. Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence. Eur Respir Rev. 2018;27(150):180074.
   PubMed Web of Science ®Google Scholar
• Judson M, Baughman R. Worsening of pulmonary sarcoidosis. Lippincott Williams Wilkins. 2014;20(5):508–516.
   Google Scholar
• Spruit MA. Pulmonary rehabilitation. Eur Respir Rev. 2014;23(131):55–63.
   PubMedGoogle Scholar
• Nakazawa A, Cox NS, Holland AE. Current best practice in rehabilitation in interstitial lung disease. Ther Adv Respir Dis. 2016;11(2):115–128.
   PubMed Web of Science ®Google Scholar
• Holland AE, Hill C. Physical training for interstitial lung disease. Cochrane Database Syst Rev. 2008; 4:CD006322.
   Google Scholar
• Yu X, Li X, Wang L, et al. Pulmonary rehabilitation for exercise tolerance and quality of life in IPF patients: a systematic review and meta-analysis. Biomed Res Int. 2019;2019:8498603.
   Google Scholar
• Divisi D, Di Francesco C, Di Leonardo G, et al. Preoperative pulmonary rehabilitation in patients with lung cancer and chronic obstructive pulmonary disease. Eur J Cardiothorac Surg. 2013;43(2):293–296.
   PubMed Web of Science ®Google Scholar
• Morano MT, Araújo AS, Nascimento FB, et al. Preoperative pulmonary rehabilitation versus chest physical therapy in patients undergoing lung cancer resection: a pilot randomized controlled trial. Arch Phys Med Rehabil. 2013;94(1):53–58.
   PubMed Web of Science ®Google Scholar
• Dassios T, Katelari A, Doudounakis S, et al. Aerobic exercise and respiratory muscle strength in patients with cystic fibrosis. Respir Med. 2013;107(5):684–690.
   PubMed Web of Science ®Google Scholar
• Lacasse Y, Martin S, Lasserson TJ, et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease: a cochrane systematic review. Eura Medicophys. 2007;43(4):475–485.
   PubMedGoogle Scholar
• Ubolnuar N, Tantisuwat A, Thaveeratitham P, et al. Effects of breathing exercises in patients with chronic obstructive pulmonary disease: Systematic review and Meta-analysis. Ann Rehabil Med. 2019;43(4):509–523.
   PubMedGoogle Scholar
• Williams VA, Bruton A, Ellis-Hills C, et al. The effect of pulmonary rehabilitation on perceptions of breathlessness and activity in COPD patients: a qualitative study. Prim Care Respir J. 2010;19(1):45–51.
   PubMedGoogle Scholar
• Cheng L, Tan B, Yin Y, et al. Short- and long-term effects of pulmonary rehabilitation for idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Clin Rehabil. 2018;32(10):1299–1307.
   PubMed Web of Science ®Google Scholar
• Gomes-Neto M, Silva CM, Ezequiel D, et al. Impact of pulmonary rehabilitation on exercise tolerance and quality of life in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis. J Cardiopulm Rehabil Prev. 2018;38(5):273–278.
   PubMed Web of Science ®Google Scholar
• Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824.
   PubMed Web of Science ®Google Scholar
• Raghu G, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: Treatment of idiopathic pulmonary fibrosis: Executive summary an update of the 2011 clinical practice guideline. 2015. RCCM2015061063ST 3.19 (thoracic.org)
   Google Scholar
• Nishiyama O, Taniguchi H, Kondoh Y, et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis: what is the main contributing factor? Respir. Med. 2005;99(4):408–414.
   PubMed Web of Science ®Google Scholar
• Sciriha A, Lungaro-Mifsud S, Fsadni P, et al. Pulmonary rehabilitation in patients with interstitial lung disease: the effects of a 12-week programme. Respir Med. 2019;146:49–56. Epub 2018 Nov
   PubMed Web of Science ®Google Scholar
• Mahler D, Wells C. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93(3):580–586.
   PubMed Web of Science ®Google Scholar
• Chang JA, Curtis JR, Patrick DL, et al. Assessment of health-related quality of life in patients with interstitial lung disease. Chest. 1999;116(5):1175–1182.
   PubMed Web of Science ®Google Scholar
• Papiris SA, Daniil ZD, Malagari K, et al. The medical research council dyspnea scale in the estimation of disease severity in idiopathic pulmonary fibrosis. Respir Med. 2005;99(6):755–761.
   PubMed Web of Science ®Google Scholar
• Mahler DA, Weinberg DH, Wells CK, et al. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984;85(6):751–758.
   PubMed Web of Science ®Google Scholar
• Polatli M, Yorgancioğlu A, Aydemir Ö, et al. Validity and reliability of turkish version of St. George's respiratory questionnaire. Tuberk Toraks. 2013;61(2):81–87.
   PubMedGoogle Scholar
• Peng S, Li Z, Kang J, et al. Cross-sectional and longitudinal construct validity of the Saint George’s respiratory questionnaire in patients with IPF. Respirology. 2008;13(6):871–879.
   PubMed Web of Science ®Google Scholar
• Swigris JJ, Brown KK, Behr J, et al. The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med. 2010;104(2):296–304.
   PubMed Web of Science ®Google Scholar
• PRISMA Preferred Reporting Items for Systematic Reviews and Meta-analyses. [Internet]. Transparent Reporting of systematic Reviews and Meta-analyses. 2020. Available at: http://www.prisma-statement.org/.
   Google Scholar
• PROSPERO International Prospective Register of Systematic Reviews. [Internet]. National Institute of Health Research. 2020. Available at: https://www.crd.york.ac.uk/PROSPERO/.
   Google Scholar
• McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22(3):276–282. PMID: 23092060; PMCID: PMC3900052.
   PubMed Web of Science ®Google Scholar
• Alboukadel. Kappa coefficient interpretation. [Internet]. Data Novia. 2020. Available at: Kappa Coefficient Interpretation: Best Reference - Datanovia Accessed December 15, 2020
   Google Scholar
• Singh SJ, Puhan MA, Andrianopoulos V, et al. An official systematic review of the European respiratory society/american thoracic society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1447–1478.
   PubMed Web of Science ®Google Scholar
• Alhamad EH. The six-minute walk test in patients with pulmonary sarcoidosis. Ann Thorac Med. 2009;4(2):60–64.
   PubMed Web of Science ®Google Scholar
• ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–117.
   PubMed Web of Science ®Google Scholar
• PEDro statistics. [Internet]. Physiotherapy Evidence Database. 2020. Available at: https://pedro.org.au/english/learn/pedro-statistics/. Accessed December 15, 2020.
   Google Scholar
• Maher CG, Sherrington C, Herbert RD, et al. Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther. 2003;83(8):713–721.
   PubMed Web of Science ®Google Scholar
• Vainshelboim B, Oliveira J, Fox BD, et al. Long-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis. Lung. 2015;193(3):345–354. Epub 20150303.
   PubMed Web of Science ®Google Scholar
• Naz I, Ozalevli S, Ozkan S, et al. Efficacy of a structured exercise program for improving functional capacity and quality of life in patients with stage 3 and 4 sarcoidosis a randomized control trial. Journal of Cardiopul Rehabil Preven. 2018;38(2):124–130.
   PubMed Web of Science ®Google Scholar
• Perez-Bogerd S, Wuyts W, Barbier V, et al. Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: a randomised controlled trial. Respir Res. 2018;19(1):181–191.
   PubMedGoogle Scholar
• Karadall MN, Bo Nak-Guclu M, Camc O Lu B, et al. Effects of inspiratory muscle training in subjects with sarcoidosis: a randomized controlled clinical trial. Respiratory Care. 2016;61(4):483–494.
   PubMed Web of Science ®Google Scholar
• Dale MT, McKeough ZJ, Munoz PA, et al. Exercise training for asbestos-related and other dust-related respiratory diseases: a randomised controlled trial. BMC Pulm Med. 2014;14:180–189.
   PubMed Web of Science ®Google Scholar
• Holland AE, Hill CJ, Conron M, et al. Short-term improvements in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax. 2008;63(6):549–554.
   PubMed Web of Science ®Google Scholar
• Nishiyama O, Kondoh Y, Kimura T, et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2008;13(3):394–399.
   PubMed Web of Science ®Google Scholar
• Vainshelboim B, Oliveira J, Yehoshua L, et al. Exercise training-based pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis. Respiration. 2014;88(5):338–378.
   Web of Science ®Google Scholar
• Dowman L, Hill CJ, Holland AE. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev. 2014(10):CD006322.
   PubMed Web of Science ®Google Scholar
• Medline Plus. 2020. Langerhans cell histiocytosis. NIH US National Library of Medicine. MedlinePlus Genetics
   Google Scholar
• Loveman E, Copley VR, Colquitt J, et al. The clinical effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: a systematic review and economic evaluation. Health Technol Assess. 2015;19(20):i–336.
   PubMed Web of Science ®Google Scholar